Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone injection for radial tunnel syndrome pain
IRCT20220129053864N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of triamcinolone in Radial Tunnel Syndrome (RTS) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Quick Disabilities of the Arm, Shoulder and Hand, Visual Analog Scale and 3 more. Started Mar 2023; status: completed.
02
Drugs
triamcinolone
03
Conditions
Radial Tunnel Syndrome (RTS)
Beyond the preview
Go deeper on IRCT20220129053864N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220129053864N1.